Community

Share Your Story, Inspire Hope

Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this form to be featured.

Latest News

Emerging Treatments in Systemic Sclerosis-Associated Interstitial Lung Disease

The pipeline for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) therapies is expanding, with companies like Genentech and GlaxoSmithKline developing treatments. Clinical trials show promising results for emerging medications, aiming to improve patient outcomes and quality of life. Continued research and collaboration foster hope for those affected by this challenging condition.

Community

Share Your Story, Inspire Hope

Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this form to be featured.

Latest News

Living with Chronic Gastrointestinal Issues Due to Scleroderma

Living with scleroderma often means dealing with persistent gastrointestinal problems, such as oesophageal dysmotility, gastroparesis, and bowel issues. These symptoms can significantly impact daily life, requiring careful management and lifestyle adjustments to mitigate their effects. Understanding and addressing these gastrointestinal challenges is crucial for improving quality of life.

Skin Thickness Improvement Linked to Better Lung Health in Patients

Research shows that a reduction in skin thickness in people with scleroderma can predict improved lung health, suggesting that skin changes may be a useful indicator for monitoring lung disease progression in patients with diffuse cutaneous systemic scleroderma (dcSSc).

Condition Causes Fingers to Harden and Change Shape: Symptoms and Causes Explained

The article discusses scleroderma, a condition that causes skin and connective tissue to harden. It highlights symptoms such as swollen fingers, tight skin, and joint pain. The piece also explores the different types of scleroderma, its causes, and how it affects daily life, including photos to illustrate the physical changes.

Understanding Autoimmune Disease: Symptoms, Causes, and Treatment Options for Scleroderma Patients

Scleroderma is an autoimmune disease where the body's immune system mistakenly attacks healthy tissues, leading to thickening and hardening of the skin and potentially affecting internal organs. Symptoms can include skin tightening, joint pain, and digestive issues. Treatment focuses on managing symptoms and slowing disease progression. Early diagnosis is crucial for better outcomes.

Community

Share Your Story, Inspire Hope

Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this form to be featured.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Soquelitinib Shows Promise in Treating Lung Disease in Mice with Systemic Sclerosis

Soquelitinib, a new drug, has shown promise in treating lung disease associated with scleroderma in mouse studies. It reduced inflammation and fibrosis, improving lung function, offering potential hope for future human treatments for this debilitating aspect of the disease.

Washington Woman Shares Her Struggle with Rare Skin Condition and Raynaud's Disease

A Washington woman shares her personal struggle with scleroderma and Raynaud's disease, highlighting the challenges she faced in diagnosis and treatment, as well as her journey towards managing her symptoms and improving her quality of life. Her story aims to raise awareness and support for those affected by these conditions.

Study Reveals Why Women Are More Prone to Autoimmune Disorders

A recent study explains why women are more likely to develop autoimmune disorders, such as scleroderma, due to differences in immune system regulation and the influence of sex hormones. The findings could lead to better understanding and treatment of these conditions.

Nailfold Capillaroscopy: A Vital Tool in Diagnosing Rheumatic Diseases Medical Research 

Nailfold capillaroscopy (NFC) is a valuable diagnostic tool for assessing microvascular damage in systemic sclerosis (SSc) and other connective tissue diseases. It aids early diagnosis, particularly in Raynaud's phenomenon, and helps distinguish between primary and secondary conditions, improving patient outcomes and guiding cardiovascular risk screening.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

Latest News

Woman Shares Struggle with Rare Skin Condition and Raynaud's Symptoms

A woman from Ashington shares her personal struggle with scleroderma and Raynaud's disease, highlighting the challenges she faces with skin tightness, joint pain, and cold sensitivity. Her story aims to raise awareness about these conditions and encourage others to seek medical help if they experience similar symptoms.

One-Minute Test Could Help Diagnose Raynaud's Phenomenon in Patients Quickly

The article discusses a simple one-minute test to help diagnose Raynaud's phenomenon, a condition often associated with scleroderma. The test involves immersing your hands in cold water and observing the color changes to identify potential symptoms. This method can aid in early detection and management of scleroderma-related issues.

High DNA Mutation Rate in SSc Cells May Promote Cancer, Study Finds

A study found that cells from people with systemic scleroderma (SSc) have a high rate of DNA mutations, which can increase the risk of cancer. This discovery helps explain why individuals with scleroderma are more likely to develop certain types of cancer. Understanding these mutations could lead to better treatments.

New Drug Avacopan Proves Effective in Treating Severe Vasculitis Cases

A new study finds that the drug avacopan is effective in treating the most serious cases of vasculitis, a condition where the immune system attacks blood vessels. This could be promising for people with scleroderma, as vasculitis is a common complication of the disease. Avacopan reduces inflammation and improves symptoms.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Amgen Partners with National Scleroderma Foundation for GivingTuesday Match

The National Scleroderma Foundation partners with Amgen Rare Disease for GivingTuesday, matching donations up to £25,000. This collaboration supports research, education, and community aid. GivingTuesday, on 3 December 2024, encourages global generosity. Contributions will be doubled, enhancing efforts to combat scleroderma. Join us in this impactful initiative.

Gastrointestinal Symptoms in SSc Affect Quality of Life and Employment

Gastrointestinal symptoms in systemic sclerosis (SSc) patients significantly affect quality of life, physical function, and mental health, but not mortality. Severe symptoms lead to higher unemployment and emotional distress. Despite challenges, understanding these impacts can guide better support and care, fostering hope and resilience in affected individuals.

Men's Online Support Group for Scleroderma: Join Us Now!

Lung Foundation Australia and Scleroderma Australia offer an online support group for men affected by scleroderma. This community provides a judgement-free space to share experiences, resources, and encouragement. Meetings occur monthly, and membership is open to all, regardless of lung involvement. Join via the QR code on the flyer.

Scleroderma Diagnosis: A Journey of Resilience and Hope

Tomisa Starr shares her 30-year journey with scleroderma, highlighting the challenges of diagnosis and treatment. Despite initial misdiagnoses, she eventually found care at Stanford University. Her story, filled with personal anecdotes, aims to bring awareness and support to others facing similar struggles with this rare disease.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Lower Bone Density in Systemic Sclerosis Patients, Especially Younger Women

Patients with systemic sclerosis, especially younger women, have lower bone mineral density than the general population. This study emphasizes the need for regular bone health assessments for all patients, as factors like finger ulcers and diffuse skin involvement can worsen this condition, highlighting the value of early intervention.

Double Lung Transplant Patient Celebrates Life with Annual Gratitude Visit

Russ Kosteniuk, a double lung transplant recipient, returns each year to thank his team at Michigan Medicine. Diagnosed with pulmonary fibrosis, he underwent a successful transplant in 2008. His ongoing gratitude showcases the supportive care he received, reinforcing the lasting bonds in patient care.

Systemic Sclerosis: Challenges in Diagnosis and Treatment Unmet Needs Persist

Systemic sclerosis is a complex autoimmune disease that’s hard to diagnose due to its rarity and non-specific symptoms. Misdiagnoses are common, and the disease has significant unmet needs in treatment. Advances in diagnostic tools and therapies are essential for improving patient outcomes and quality of life.

Gastrointestinal Symptoms in SSc Affect Quality of Life and Employment

Gastrointestinal symptoms in systemic sclerosis significantly impact patients' quality of life, mental health, and employment status. Though mortality is unaffected, severe symptoms lead to mental distress and higher unemployment, underscoring the need for targeted support to help patients manage these life-altering effects.

In the News

Webinar Series on Systemic Sclerosis Management and Guidelines

The webinar series, led by Professor Christopher Denton, explores the 2024 BSR guidelines for systemic sclerosis management. It covers SSc assessment, classification, and treatment, focusing on cardiorespiratory and vasculopathy complications. The series aims to enhance understanding and implementation of these guidelines in clinical practice, fostering a supportive community.

CAL101 Shows Promise in Treating Fibrosis in Early Trials

CAL101, developed by Calluna Pharma, is a promising treatment for fibrosis in scleroderma, showing safety and tolerability in Phase 1 trials. Targeting the S100A4 protein, it aims to prevent fibrosis. Encouraged by these results, Calluna plans Phase 2 trials in 2025, offering hope for fibrotic diseases.

Men's Health in Scleroderma: Addressing Gender Disparities in Outcomes

The study highlights that men with scleroderma-associated pulmonary hypertension face worse outcomes than women, with more cardiovascular events and reduced survival. The absence of protective estrogen and testosterone's negative effects may contribute. Gender-specific management, including early cardiac assessments and hormonal therapies, is recommended to improve prognosis.

Morphea: Understanding and Treating Localised Scleroderma Today

The article discusses the rising incidence of morphea, a form of localized scleroderma, and reviews current treatment options. Despite ongoing research, no highly specific therapies exist yet. However, new studies offer hope for future treatments that could better address both inflammation and fibrosis, providing optimism for patients and their families.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Understanding Calcinosis in Systemic Sclerosis: Causes and Challenges

The article explores the complex pathogenesis of calcinosis in systemic sclerosis, highlighting its significant impact on patients' quality of life. It discusses potential causes, including cellular changes and mitochondrial dynamics, and emphasises the need for targeted treatments. Understanding these mechanisms offers hope for improved management and support for affected individuals.

Autophagy's Role in Skin Health and Disorders

Autophagy, a vital cellular process, maintains cellular balance and impacts skin disorders like psoriasis and lupus. This review explores three autophagy types—macrophage, chaperone-mediated, and microphagy—and their roles in six dermatological conditions, offering insights for future research and potential therapeutic strategies.

New Guidelines for Systemic Sclerosis and Behçet's Management

The British Society for Rheumatology has released new guidelines for systemic sclerosis and Behçet's, emphasising early diagnosis, organ-specific management, and psychological care. These guidelines aim to enhance understanding and support for patients, offering resources like summary sheets and patient information leaflets to aid healthcare professionals.

Strengthening Community Bonds at ReumaExpo in Puerto Rico

Lorraine Biaggi and Monica Ramirez from the National Scleroderma Foundation participated in ReumaExpo 2024 in Puerto Rico, enhancing community ties. They shared personal experiences and strategies to raise awareness. Their efforts culminated in the chapter's first in-person meet-and-greet, marking a significant milestone in community engagement.

Digital Innovation in the NHS

Digital Patient Passports to Revolutionise NHS Healthcare

Wes Streeting, the health secretary, has unveiled an ambitious plan to revolutionise healthcare in the UK by introducing patient passports, which will digitally store all NHS medical records in one accessible location. This transformative initiative aims to enhance patient care by allowing swift access to health data for GPs, hospitals, and ambulance services, thereby reducing repeat tests and medication errors. The digital data bill will standardise information systems across the NHS, creating a unified patient record on the NHS app. 

Despite the potential benefits, concerns about privacy and data security have been raised. Critics, including medConfidential, warn that the centralised database could become a target for hackers and misuse by unauthorised personnel. Public scepticism is evident, with a significant portion of the population expressing distrust in the NHS's ability to keep data secure. 

Streeting, however, remains optimistic, emphasising the collaboration with tech and pharma companies to develop new treatments and ensure the NHS benefits from cutting-edge advancements. He assures that patient data will be protected and anonymised, addressing fears of "big brother" oversight. The government is also focusing on shifting healthcare from hospitals to community-based centres and prioritising prevention over treatment, with plans to distribute wearable tech for health monitoring. 

This bold vision for the NHS seeks to harness the power of digital innovation to improve healthcare delivery, but it must navigate the delicate balance between technological advancement and patient privacy.

Community Voices

Have Your Say